From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists

From Bradykinin B2 Receptor Antagonists to Orally Active and Selective Bradykinin B1 Receptor Antagonists Bradykinin Receptor Antagonists Containing N-Substituted Amino Acids:  In Vitro and in Vivo B₂ and B₁ Receptor Antagonist Activity Synthesis and Biological Evaluation of Bradykinin B₁/B₂ and Selective B₁ Receptor Antagonists Quinolinyl- and phenantridinyl-acetamides as bradykinin B1 receptor antagonists Highly Selective Bradykinin Agonists and Antagonists with Replacement of Proline Residues byN-Methyl-<scp>d</scp>- and<scp>l</scp>-phenylalanine Design and Synthesis of Potent Bradykinin Agonists Containing a Benzothiazepine Moiety Identification of a Nonpeptidic and Conformationally Restricted Bradykinin B1 Receptor Antagonist with Anti-Inflammatory Activity Synthesis and Characterization of Bradykinin B₂ Receptor Agonists Containing Constrained Dipeptide Mimics Design and synthesis of selective α1B adrenoceptor antagonists Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?